Filtered By:
Education: Study

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 164 results found since Jan 2013.

Should Fluoro be Your New Go-To?
Part Three in a Three-Part Series   This is the third and final part of our series on foreign bodies and fluoroscopy. Click here for part one and here for part two.   This month, we walk you through a step-by-step guide with bonus video footage to aid in your technique. This progressive procedure is absolutely significant to your practice, and we hope you all get a chance to try it.     The Approach n        Identification of foreign body on plain film or ultrasound n         Saphenous or posterior tibial nerve block n         Enlargement of the wound or entrance site using incision...
Source: The Procedural Pause - January 4, 2016 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs

MassDevice.com +3 | The top 3 medtech stories for December 16, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. Ex-GC sues Bio-Rad, alleging retaliation for blowing the whistle The former general counsel for Bio-Rad accused the company and CEO Norman Schwartz of firing him in retaliation for blowing the whistle on alleged violations of the Foreign Corrupt Practices Act in China. Sanford Wadler, who was ...
Source: Mass Device - December 16, 2015 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news

Arch Therapeutics wins EU nod for AC5 hemostat trial
Arch Therapeutics (OTC:ARTH) said it won approval for a European safety-and-efficacy study of its AC5 surgical hemostat in bleeding wounds incurred during dermatology procedures. Framingham, Mass.-based Arch said the endpoints for the single-blinded study of up to 50 patients include time to hemostasis and product-related adverse effects at 30 days. One arm of the trial will include patients taking blood thinning drugs, the company said. The 1st patient is expected to enter the trial early next year, with data due within 2 quarters, according to the company. Arch bills AC5 as designed to stop bleeding in seconds, rath...
Source: Mass Device - December 16, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Surgical Clinical Trials Arch Therapeutics Source Type: news

Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats
Conclusion: Costs and HRU for patients treated with ORCs were lower than or similar to patients treated with OAHs. Proper selection of the appropriate hemostatic agents has the potential to influence clinical outcomes and treatment costs. Keywords: hemostatics, hemostatic techniques, blood transfusion, health care costs, surgical blood loss
Source: ClinicoEconomics and Outcomes Research - November 5, 2015 Category: Health Management Tags: ClinicoEconomics and Outcomes Research Source Type: research

Development of an ovine model of occlusive arterial injury for the evaluation of endovascular interventions.
Abstract Endovascular intervention for occlusive arterial trauma is becoming more common in clinical practice. The aim of this study is to present an ovine model of extremity arterial injury for use in future endovascular translational research. Animals under general anesthesia had their left superficial femoral artery exposed, which was bluntly injured over a 2-cm section using a hemostat and injection of air. Occlusion was confirmed on angiography and the flow characteristics measured by ultrasonography. Of five animals enrolled, four occluding lesions were created successfully. Post injury, there was a signific...
Source: Vascular - November 5, 2015 Category: Surgery Authors: Reva VA, Morrison JJ, Denisov AV, Seleznev AB, Zhabin AV, Bozhedomova ER, Samokhvalov IM Tags: Vascular Source Type: research

Tap that Knee! Basics of Arthrocentesis
Part 2 of a Series   Our series on joint care has given you a basic overview on knee arthrocentesis. Typically, it is not necessary to have an orthopedic consultant come to the bedside in the emergency department to do this procedure. Arthrocentesis is a procedure you can do well and feel confident about your technique.   Take a moment to review our last blog post on knee pain before reading this post and watching the accompanying video. (http://bit.ly/1Q7dG4h.) As always, review the anatomy; it plays a key part in successful bedside technique. Ultrasound-guided arthrocentesis is always a favored approach.   Although em...
Source: The Procedural Pause - October 1, 2015 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs

Initial experiences with the Hemopatch ® as a hemostatic agent in zero-ischemia partial nephrectomy
Conclusions Although this study is limited to a small set of initial experiences with Hemopatch® in LPN, it proves the feasibility and reliability of this new hemostat. Following further evaluation in prospective randomized comparative studies, Hemopatch® might represent a promising tool in NSS.
Source: World Journal of Urology - September 26, 2015 Category: Urology & Nephrology Source Type: research

Most Don't Need 'Bridging' When They Stop Warfarin Temporarily
In this study, Ortel's team randomly assigned patients to take either heparin or an inactive placebo during that time window.In the end, heparin showed no effect on blood-clot risk. Just 0.3 percent of treated patients developed a clot within a month of their procedure, versus 0.4 percent of patients given the placebo, the study found.On the other hand, heparin did boost the odds of serious bleeding. Just over 3 percent of patients developed "major" bleeding, compared with just over 1 percent of placebo patients, the study found.The findings suggest that bridging is unnecessary for most atrial fibrillation patients, Ortel ...
Source: Medical Hemostat - August 26, 2015 Category: Medical Equipment Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs

Most Don ' t Need ' Bridging ' When They Stop Warfarin Temporarily
In this study, Ortel ' s team randomly assigned patients to take either heparin or an inactive placebo during that time window. In the end, heparin showed no effect on blood-clot risk. Just 0.3 percent of treated patients developed a clot within a month of their procedure, versus 0.4 percent of patients given the placebo, the study found. On the other hand, heparin did boost the odds of serious bleeding. Just over 3 percent of patients developed " major " bleeding, compared with just over 1 percent of placebo patients, the study found. The findings suggest that bridging is unnecessary for most atrial fibrillation ...
Source: Medical Hemostat - August 26, 2015 Category: Medical Equipment Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs

The effect of CoolClot hemostatic agent on skin wound healing in rats
Hemostatic agents can play a key role in controlling severe hemorrhage after trauma. Previously, some criteria have been defined for improving the quality of these products; one of them is that the hemostat causes no further tissue injury. CoolClot is a recently introduced hemostatic agent that its effects on wound healing have not yet been examined, which this study aims to address.
Source: Journal of Surgical Research - August 21, 2015 Category: Surgery Authors: Hadi Khoshmohabat, Behnam Dalfardi, Amir Reza Dehghanian, Hamid Reza Rasouli, S.M.J. Mortazavi, Shahram Paydar Source Type: research

Medtech approvals: FDA releases June 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in June 2015: Summary of PMA Originals & Supplements Approved Originals: 5 Supplements: 80 Summary of PMA Originals Under Review Total Under Review: 53 Total Active: 22 Total On Hold: 31 Summary of PMA Supplements Under Review Total Under Review: 575 Total Active: 418 Total On Hold: 157 Summary of All PMA Submissions Originals: 4 Supplements: 72 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 80 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 115.2 FDA Time: 97.1 ...
Source: Mass Device - August 20, 2015 Category: Medical Equipment Authors: MassDevice Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Erythropoietin Attenuates the Apoptosis of Adult Neurons After Brachial Plexus Root Avulsion by Downregulating JNK Phosphorylation and c-Jun Expression and Inhibiting c-PARP Cleavage
In conclusion, the apoptosis of adult spinal motorneurons was associated with JNK phosphorylation, c-Jun expression, and caspase activity, and EPO-mediated neuronal protective effect is proved by downregulating the JNK phosphorylation and c-Jun expression and inhibiting of c-PARP cleavage.
Source: Journal of Molecular Neuroscience - August 1, 2015 Category: Neuroscience Source Type: research

Dabbling in Dentistry
Most people will experience dental pain or a dental complication at some point in their lives. Dental pain is an incredibly common complaint by people of all ages, especially those who lack dental insurance and suitable hygiene habits. Sometimes, though, poor dentition or injury is simply a result of bad luck. Patients often present to the ED hoping to find a dentist and an answer to their problems.   Your first thought? “I am not a dentist. What am I going to do?” You’re right to an extent. We are not dentists, and often feel we have little to offer patients for acute issues that require equipment we don’t have a...
Source: The Procedural Pause - July 1, 2015 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs